Tetratherix Limited (ASX:TTX)
Australia · Delayed Price · Currency is AUD 7.70
+0.16 (2.12%)
Aug 7, 2026, 4:10 PM AEST
Tetratherix Market Cap
Tetratherix has a market cap or net worth of 408.52 million as of August 7, 2026. Its market cap has increased by 87.45% in one year.
Market Cap
408.52M
Enterprise Value
398.17M
Revenue
2.00M
Ranking
n/a
PE Ratio
n/a
Stock Price
7.70
ChartMarket Cap Chart
Since June 30, 2025, Tetratherix's market cap has increased from 152.00M to 408.52M, an increase of 168.76%. That is a compound annual growth rate of 144.84%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 7, 2026 | 408.52M | 147.46% |
| Dec 30, 2025 | 165.09M | 8.61% |
| Jun 30, 2025 | 152.00M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Clarity Pharmaceuticals | 1.01B |
| Clinuvel Pharmaceuticals | 470.49M |
| Racura Oncology | 402.85M |
| Starpharma Holdings | 336.92M |
| Orthocell | 198.75M |
| BLS Pharmaceuticals | 197.78M |
| Nyrada | 182.70M |
| Dimerix | 174.12M |